765 Whole-genome landscapes of major melanoma subtypes.
http://www.nature.com/nature/journal/v545/n7653/full/nature22071.html
764 Leukotriene B4 antagonism ameliorates experimental lymphedema.
http://stm.sciencemag.org/content/9/389/eaal3920
763 The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
http://www.nature.com/ncb/journal/v19/n5/abs/ncb3513.html
762 Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.
https://www.nature.com/nature/journal/v545/n7652/full/nature22311.html
761 Modulating the therapeutic response of tumours to dietary serine and glycine starvation.
http://www.nature.com/nature/journal/v544/n7650/full/nature22056.html
760 The cross-talk between immune cells and blood vessel endothelial cells promotes pericyte coverage and decreases hypoxia in mouse tumour models, and correlative evidence suggests that these processes influence cancer prognosis in humans.
http://www.nature.com/nature/journal/v544/n7649/full/nature21724.html
759 Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.
http://stm.sciencemag.org/content/9/385/eaak9670
758 Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
http://science.sciencemag.org/content/356/6334/200
757 Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
http://science.sciencemag.org/content/356/6334/200
756 Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
http://stm.sciencemag.org/content/9/384/eaai8504
755 Rabies Virus-Inspired Silica-Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201605563/full
754 The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1.
http://www.nature.com/nature/journal/v543/n7647/full/nature21702.html
753 Effective combinatorial immunotherapy for castration-resistant prostate cancer.
http://www.nature.com/nature/journal/v543/n7647/full/nature21676.html
752 LACTB is a tumour suppressor that modulates lipid metabolism and cell state.
http://www.nature.com/nature/journal/v543/n7647/full/nature21408.html
751 A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.
http://www.nature.com/nature/journal/v543/n7647/full/nature21713.html
750 Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention.
http://science.sciencemag.org/content/355/6331/1330
749 Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
http://www.nature.com/nature/journal/v543/n7645/full/nature21409.html
748 Integrated genomic and molecular characterization of cervical cancer.
http://www.nature.com/nature/journal/v543/n7645/full/nature21386.html
747 Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia.
http://www.nature.com/articles/ncomms14756
746 Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
http://www.pnas.org/content/114/12/E2357.abstract
|
